Research Project
Grant-in-Aid for Scientific Research (C)
The aim of study was to develop an in vitro selection system using human immunodeficiency virus type 1 (HIV-1) by multi anti-HIV drugs. In this study, we determined that (i) the HIV integrase inhibitor raltegravir (RAL)-resistant clone became highly sensitive to the CCR5 antagonist maraviroc (MVC) and (ii) MVC-resistant clone became highly sensitive to the anti-envelope (Env) neutralizing antibodies, respectively.Furthermore, using established this system, it was determined that acquisitions of resistance mutations were significantly decreased during in vitro selection by multi anti-HIV drugs rather than only single drugs. Thus, this novel system is indicated a useful tool for investigating the compatibility of combined anti-retroviral therapy.
All 2015 2014 2013 2012
All Journal Article (4 results) (of which Peer Reviewed: 4 results, Acknowledgement Compliant: 1 results) Presentation (28 results)
Journal of General Virology
Volume: 95 Issue: 8 Pages: 1816-1826
10.1099/vir.0.062885-0
Bioorg. Med. Chem.
Volume: 21 Issue: 24 Pages: 7884-7889
10.1016/j.bmc.2013.10.005
Volume: 8 Issue: 9 Pages: 2518-2526
10.1016/j.bmc.2013.02.041
Volume: 94 Issue: 5 Pages: 933-943
10.1099/vir.0.047167-0